Proteome Sciences hires Glenn Barney
This article was originally published in Scrip
Executive Summary
Glenn Barney has joined Proteome Sciences as vice-president of business development in North America. Mr Barney's most recent position was vice-president of business development for NextGen Sciences, where he commercialised a suite of services for biomarker discovery. Similarly at Proteome Sciences, he will focus on driving revenue through the company's biomarker services and assays.
You may also be interested in...
Almirall launches Constella in six European markets
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira raises $35m in series B
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis ups public offering to $240m
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.